Finally, since the start of the Heartwatch programme, pharmacological management of cardiovascular disease has been altered by new evidence and advice on medications such as aspirin, direct oral anticoagulants, beta-blocker types, and newer agents that act on the renin-angiotensin-aldosterone system. This evidence concerns the gene REN and cardiovascular disorder.